Skip to main content

Table 2 Age, sex, and survival rates of eCCA patients based on ALBI grade

From: The prognostic role of albumin-bilirubin grade in the mortality of extrahepatic cholangiocarcinoma patients

Variable

Total

(N = 80)

ALBI Grades

P-Value

Grade 1

(N = 15)

Grade 2

(N = 34)

Grade 3

(N = 31)

Age (years)

67(58.25-74)

64(53–72)

68.50(58.25–76.25)

69(58–74)

0.411

Sex,

N (%)

Female

26(32.5)

8(53.3)

11(32.4)

7(22.6)

0.113

Male

54(67.5)

7(46.7)

23(67.6)

24(77.4)

Survival 1-year,

N (%)

No

49(61.3)

8(53.3)

18(52.9)

23(74.2)

0.168

Yes

31(38.8)

7 (46.7)

16 (47.1)

8 (25.8)

Survival 3-year,

N (%)

No

69(86.3)

12(80)

28(82.4)

29(93.5)

0.313

Yes

11(13.8)

3(20)

6(17.6)

2(6.5)

Survival 5-year,

N (%)

No

77(96.3)

14(93.3)

32(94.1)

31(100)

0.370

Yes

3(3.8)

1(6.7)

2(5.9)

0(0)

  1. Chi square test (in qualitative variables) and Kruskal Wallis Test (in quantitative variables) were used to analyze data
  2. P < 0.05 was considered significant in all tests
  3. Abbreviations: albumin-bilirubin ratio (ALBI), extrahepatic cholangiocarcinoma (eCCA)